Burling Wealth Partners LLC Purchases 1,438 Shares of Stryker Corporation (NYSE:SYK)

Burling Wealth Partners LLC lifted its stake in Stryker Corporation (NYSE:SYK - Free Report) by 26.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,806 shares of the medical technology company's stock after buying an additional 1,438 shares during the period. Burling Wealth Partners LLC's holdings in Stryker were worth $2,534,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in SYK. Capital A Wealth Management LLC bought a new position in Stryker during the fourth quarter worth about $26,000. Goodman Advisory Group LLC bought a new position in shares of Stryker in the first quarter valued at approximately $32,000. City Holding Co. raised its stake in shares of Stryker by 528.6% in the first quarter. City Holding Co. now owns 88 shares of the medical technology company's stock valued at $33,000 after acquiring an additional 74 shares during the last quarter. VSM Wealth Advisory LLC bought a new position in shares of Stryker in the fourth quarter valued at approximately $36,000. Finally, Smallwood Wealth Investment Management LLC bought a new position in shares of Stryker in the first quarter valued at approximately $40,000. Institutional investors own 77.09% of the company's stock.

Insider Buying and Selling

In related news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the transaction, the director owned 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 5.90% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on SYK. BTIG Research reiterated a "buy" rating on shares of Stryker in a research note on Monday. Wall Street Zen lowered shares of Stryker from a "buy" rating to a "hold" rating in a report on Friday, June 27th. Citigroup reissued a "buy" rating and issued a $455.00 price target (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Truist Financial raised their price target on shares of Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a report on Monday, May 5th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $442.00 price target on shares of Stryker in a report on Friday, March 21st. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $428.55.

Stryker Trading Up 0.1%

Shares of NYSE:SYK opened at $390.97 on Thursday. The company's 50-day moving average price is $385.38 and its two-hundred day moving average price is $377.55. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. Stryker Corporation has a one year low of $314.93 and a one year high of $406.19. The stock has a market capitalization of $149.23 billion, a PE ratio of 52.79, a price-to-earnings-growth ratio of 2.95 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. Stryker's quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.50 EPS. On average, equities analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be paid a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. Stryker's dividend payout ratio (DPR) is currently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.